IP Library Granted Patent US 9,217,033
Granted Patent B2
US 9,217,033 · App. 14/176,790 · Granted Dec 22, 2015

Monoclonal antibodies against Glypican-3

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,217,033
App. No.
14/176,790
Granted
Dec 22, 2015
Kind
B2
Abstract

The present disclosure provides isolated monoclonal antibodies, particularly human monoclonal antibodies that specifically bind to Glypican-3 with high affinity. Nucleic acid molecules encoding Glypican-3 antibodies, expression vectors, host cells and methods for expressing the Glypican-3 antibodies are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the Glypican-3 antibodies are also provided. Methods for detecting Glypican-3, as well as methods for treating various Glypican-3-related conditions, including hepatocellular cancer, are disclosed.

Claims (15)

1. An isolated nucleic acid molecule encoding;

(a) a heavy chain of an anti-Glypican-3 antibody, or antigen-binding portion thereof, wherein the heavy chain variable region comprises the amino acid sequence of SEQ ID NO: 19; or

(b) a light chain of an anti-Glypican-3 antibody, or antigen-binding portion thereof, wherein the light chain variable region comprises the amino acid sequence of SEQ ID NO: 22.

2. The nucleic acid molecule of claim 1 , comprising the nucleotide sequence of SEQ ID NO: 25.

3. The nucleic acid molecule of claim 1 , comprising the nucleotide sequence of SEQ ID NO: 28.

4. The nucleic acid molecule of claim 1 , encoding a heavy chain and a light chain of an anti-Glypican-3 antibody, or antigen-binding portion thereof, wherein the heavy chain variable region comprises the amino acid sequence of SEQ ID NO: 19 and the light chain variable region comprises the amino acid sequence of SEQ ID NO: 22.

5. An expression vector comprising the nucleic acid molecule of claim 1 .

6. A host cell comprising the expression vector of claim 5 .

7. A method for preparing an anti-Glypican-3 antibody, which comprises:

(a) obtaining a host cell that contains a nucleic acid molecule encoding the amino acid sequence of SEQ ID NO: 19 and a nucleic acid molecule encoding the amino acid sequence of SEQ ID NO: 22;

(b) growing the host cell in a host cell culture;

(c) providing host cell culture conditions wherein the nucleic acid molecules are expressed; and

(d) recovering the antibody from the host cell or from the host cell culture.

8. A method according to claim 7 , wherein the nucleic acid molecule encoding the amino acid sequence of SEQ ID NO: 19 and the nucleic acid molecule encoding the amino acid sequence of SEQ ID NO: 22 are inserted into separate expression vectors.

9. A method according to claim 7 , wherein the nucleic acid molecule encoding the amino acid sequence of SEQ ID NO: 19 and the nucleic acid molecule encoding the amino acid sequence of SEQ ID NO: 22 are inserted into the same expression vector.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2015
From: TERRETT, JONATHAN ALEXANDER; LU, LI-SHENG; HUANG, HAICHUN; YAO, DAPENG; PAN, CHIN; LEBLANC, HEIDI; SPROUL, TIMOTHY; YAMANAKA, MARK
To: MEDAREX, INC.
Reel/Frame 036245/0419 →
MERGER Recorded Mar 19, 2015
From: MEDAREX, L.L.C.
To: E. R. SQUIBB & SONS, L.L.C.
Reel/Frame 035226/0690 →